EUVIMEDEUVIMED entdecken
Crossref

Nesfatin‐1 Exerts a Neuroprotective Effect in Thioacetamide‐Induced Acute Hepatic Encephalopathy by Activating the PI3K /Akt/Nrf2/ HO ‐1 Pathway

Heba Faheem iD, Rana Alawadhi, Eman H Basha iD, Rasha A Abd Ellatif iD, Mona A Abdel-Kareem iD, Alaa H Abd El-Azeem iD, Alaa Elkordy iD, Nahla Anas Nasef iD, Lamees Mohamed Dawood iD, Maram Mohammed El Tabaa iD, Manar Mohammed El Tabaa iD, Fatma H Rizk iD

Comprehensive Physiology · 2025

DOI: 10.1002/cph4.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comprehensive Physiology, 2025. Verfasst von Heba Faheem und 11 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Department, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Nucleobindins, Hepatic Encephalopathy, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatic encephalopathy (HE) is a neuropsychiatric disorder associated with liver failure. Nesfatin‐1 is a neuropeptide characterized by its antioxidant and anti‐inflammatory properties.

Aim

This study aimed to evaluate the neuroprotective and hepatoprotective effects of nesfatin‐1 in a thioacetamide (TAA)‐induced rat model of acute HE. Additionally, the study aimed to examine the underlying mechanisms, particularly the role of the PI3K/Akt/Nrf2/HO‐1 signaling pathway. Materials and Methods Male Sprague Dawley rats were divided into five groups: (1) untreated control, (2) nesfatin‐1‐treated control, (3) thioacetamide‐induced hepatic encephalopathy (HE), (4) HE + nesfatin‐1, and (5) HE + nesfatin‐1 + zinc protoporphyrin IX (ZnPP IX; HO‐1 inhibitor). Assessments included behavioral analysis, serum liver function biomarkers, oxidative stress and inflammatory markers, brain water content, mRNA expression of HO‐1 (Heme Oxygenase 1) and GFAP (Glial Fibrillary Acidic Protein), PI3K/Akt/Nrf2 protein levels, as well as histological and immunohistochemical evaluations.

Results

Nesfatin‐1 significantly improved psychomotor activity, reduced serum ALT, AST, total bilirubin, and ammonia levels, and increased albumin. It also lowered brain MDA, TNF‐α, IL‐6, and CRP levels, reduced brain water content, and upregulated the expression of HO‐1 and GFAP. Furthermore, nesfatin‐1 activated the PI3K/Akt/Nrf2 pathway and inhibited the expression of caspase‐3 and NF‐κB in liver and brain tissues. These protective effects were negated by HO‐1 inhibition using ZnppIX. Histological analysis demonstrated the structural integrity of liver and brain tissues in rats treated with nesfatin‐1.

Conclusion

Nesfatin‐1 exerts potent hepatoprotective and neuroprotective effects in TAA‐induced hepatic encephalopathy via antioxidative, anti‐inflammatory, and antiapoptotic mechanisms involving the PI3K/Akt/Nrf2/HO‐1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleobindinsHepatic EncephalopathyNeuroprotective AgentsAnimalsMaleThioacetamideNF-E2-Related Factor 2Rats, Sprague-DawleyRatsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionHeme Oxygenase (Decyclizing)Oxidative Stress

Stichwörter der Autor:innen

HO‐1PI3K/Akt/Nrf2apoptosishepatic encephalopathynesfatin‐1neuroinflammationoxidative stressthioacetamide

Substanzen

NucleobindinsThioacetamideNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktNfe2l2 protein, ratNeuroprotective AgentsPhosphatidylinositol 3-KinasesHmox1 protein, ratHeme Oxygenase (Decyclizing)Nucb1 protein, rat

Autor:innen und Institutionen

  • Physiology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Science Department, College of Basic Education, Paaet, Kuwait.
  • Anatomy and Embryology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Anatomy and Embryology Department, Faculty of Medicine, Kafr El-Sheikh University, Kafr El-Sheikh, Egypt.
  • Medical Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Neuropsychiatry Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

ORCID-Profile: Heba Faheem, Eman H Basha, Rasha A Abd Ellatif, Mona A Abdel-Kareem, Alaa H Abd El-Azeem, Alaa Elkordy, Nahla Anas Nasef, Lamees Mohamed Dawood, Maram Mohammed El Tabaa, Manar Mohammed El Tabaa, Fatma H Rizk

Zitieren

APA

Faheem, H., Alawadhi, R., Basha, E. H., Abd Ellatif, R. A., Abdel-Kareem, M. A., Abd El-Azeem, A. H., Elkordy, A., Nasef, N. A., Dawood, L. M., El Tabaa, M. M., El Tabaa, M. M., & Rizk, F. H. (2025). Nesfatin‐1 Exerts a Neuroprotective Effect in Thioacetamide‐Induced Acute Hepatic Encephalopathy by Activating the PI3K /Akt/Nrf2/ HO ‐1 Pathway. Comprehensive Physiology. https://doi.org/10.1002/cph4.70039

Vancouver

Faheem H, Alawadhi R, Basha EH, Abd Ellatif RA, Abdel-Kareem MA, Abd El-Azeem AH, et al. Nesfatin‐1 Exerts a Neuroprotective Effect in Thioacetamide‐Induced Acute Hepatic Encephalopathy by Activating the PI3K /Akt/Nrf2/ HO ‐1 Pathway. Comprehensive Physiology. 2025. doi:10.1002/cph4.70039

BibTeX
@article{Faheem2025,
  author = {Faheem, Heba and Alawadhi, Rana and Basha, Eman H and Abd Ellatif, Rasha A and Abdel-Kareem, Mona A and Abd El-Azeem, Alaa H and Elkordy, Alaa and Nasef, Nahla Anas and Dawood, Lamees Mohamed and El Tabaa, Maram Mohammed and El Tabaa, Manar Mohammed and Rizk, Fatma H},
  title = {Nesfatin‐1 Exerts a Neuroprotective Effect in Thioacetamide‐Induced Acute Hepatic Encephalopathy by Activating the PI3K /Akt/Nrf2/ HO ‐1 Pathway},
  journal = {Comprehensive Physiology},
  year = {2025},
  doi = {10.1002/cph4.70039}
}
Kostenlos starten →